Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
Rheumatology (Oxford, England)|December 20, 2013
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohortRüdiger B Mueller, Toni Kaegi, Axel Finckh, et al.
Joint Bone Spine|December 19, 2015
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational studyIlias Lazarou, Axel Finckh, Lara Fischer, et al.
Arthritis and Rheumatism|April 29, 2006
Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal studyAxel Finckh, Paola de Pablo, Jeffrey N Katz, et al.
Rheumatology International|July 30, 2014
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteriaPascal Zufferey, Jacqueline Ghosn, Fabio Becce, et al.
Plos One|April 26, 2019
Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individualsMark Harrison, Luke Spooner, Nick Bansback, et al.
Revue Medicale Suisse|January 17, 2024
[Rheumatology: what's new in 2023]Kim Lauper, Axel Finckh, Stéphane Genevay, et al.
Plos One|June 29, 2021
Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural networkMaria Kalweit, Ulrich A Walker, Axel Finckh, et al.
Statistical Methods in Medical Research|April 26, 2022
Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventionsMichael Seo, Thomas Pa Debray, Yann Ruffieux, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Rheumatology (Oxford, England)|August 19, 2010
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletionUlrich A Walker, Delphine S Courvoisier, Jean Dudler, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
Rheumatology (Oxford, England)|December 20, 2013
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohortRüdiger B Mueller, Toni Kaegi, Axel Finckh, et al.
Joint Bone Spine|December 19, 2015
Low pre-treatment B-cell counts are not a risk factor of infection in patients treated with rituximab for autoimmune diseases: An observational studyIlias Lazarou, Axel Finckh, Lara Fischer, et al.
Arthritis and Rheumatism|April 29, 2006
Performance of an automated computer-based scoring method to assess joint space narrowing in rheumatoid arthritis: a longitudinal studyAxel Finckh, Paola de Pablo, Jeffrey N Katz, et al.
Rheumatology International|July 30, 2014
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteriaPascal Zufferey, Jacqueline Ghosn, Fabio Becce, et al.
Plos One|April 26, 2019
Preventing rheumatoid arthritis: Preferences for and predicted uptake of preventive treatments among high risk individualsMark Harrison, Luke Spooner, Nick Bansback, et al.
Revue Medicale Suisse|January 17, 2024
[Rheumatology: what's new in 2023]Kim Lauper, Axel Finckh, Stéphane Genevay, et al.
Plos One|June 29, 2021
Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural networkMaria Kalweit, Ulrich A Walker, Axel Finckh, et al.
Statistical Methods in Medical Research|April 26, 2022
Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventionsMichael Seo, Thomas Pa Debray, Yann Ruffieux, et al.
Arthritis Research & Therapy|March 14, 2024
Concomitant Sjögren's disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss clinical quality management cohortLisa Christ, Seraphina Kissling, Axel Finckh, et al.
Rheumatology (Oxford, England)|August 19, 2010
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletionUlrich A Walker, Delphine S Courvoisier, Jean Dudler, et al.
Pageof 23